The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways
Authors
Keywords
Epigallocatechin gallate(EGCG), 5,3′,4′,3″,4″,5″-6-0-ethyl-EGCG (Y, 6, ), Hepatocellular carcinoma, HIF-1α, Angiogenesis, Human umbilical vein endothelial cells (HUVECs)
Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 259, Issue -, Pages 112852
Publisher
Elsevier BV
Online
2020-04-10
DOI
10.1016/j.jep.2020.112852

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.